T. Nishizaki et al., NEFIRACETAM MODULATES ACETYLCHOLINE-RECEPTOR CURRENTS VIA 2 DIFFERENTSIGNAL-TRANSDUCTION PATHWAYS, Molecular pharmacology, 53(1), 1998, pp. 1-5
Nootropic agents are proposed to serve as cognition enhancers. The und
erlying mechanism, however, is largely unknown, The present study was
conducted to assess the intracellular signal transduction pathways med
iated by the nootropic nefiracetam in the native and mutant Torpedo ca
lifornica nicotinic acetylcholine (ACh) receptors expressed in Xenopus
laevis oocytes. Nefiracetam induced a short-term depression of ACh-ev
oked currents at submicromolar concentrations (0.01-0.1 mu M) and a lo
ng-term enhancement of the currents at micromolar concentrations (1-10
mu M). The depression was caused by activation of pertussis toxin-sen
sitive, G protein-regulated, cAMP-dependent protein kinase (PKA) with
subsequent phosphorylation of the ACh receptors; in contrast, the enha
ncement was caused by activation of Ca2+-dependent protein kinase C (P
KC) and the ensuing PKC phosphorylation of the receptors. Therefore, n
efiracetam interacts with PKA and PKC pathways, which may explain a ce
llular mechanism for the action of cognition-enhancing agents.